Arsenal Capital Partners, a New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, recently announced its acquisition of IGM Resins, a provider of intermediates to the global ultraviolet radiation-cure coatings, inks, and adhesives industries. Headquartered in the Netherlands, IGM Resins is a global specialty chemical company and leading supplier of photoinitiators and acrylates. 

“We are delighted with the opportunity to invest in a global company with the ability to provide complete solutions to the highly attractive UV-cure end markets,” said John Televantos, a partner at Arsenal who co-heads the firm’s Specialty Industrials practice. “The acquisition of IGM Resins further builds on Arsenal’s broad portfolio and established expertise in the Specialty Chemicals and Materials sectors.”

For additional information, visit www.arsenalcapital.com or www.igmresins.com.